<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27256" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pityriasis Rotunda</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Riley</surname>
            <given-names>Christopher A.</given-names>
          </name>
          <aff>San Antonio Uniformed Services Health Education Consortium</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Badri</surname>
            <given-names>Talel</given-names>
          </name>
          <aff>University of Tunis El Manar</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hafsi</surname>
            <given-names>Wissem</given-names>
          </name>
          <aff>Faculty of Medicine of Tunis, Tunisia</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Riley declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Talel Badri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Wissem Hafsi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27256.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pityriasis rotunda is an uncommon acquired dermatosis characterized by hyperpigmented or hypopigmented, well-defined circular or oval scaly plaques. These lesions vary in size and typically appear on the trunk and proximal limbs. The condition is linked to a disorder of keratinization, though its etiology remains unclear. While it is more prevalent in certain populations, pityriasis rotunda can be challenging to diagnose, particularly in regions where it is less common. Early recognition is crucial for distinguishing it from other dermatological conditions, as it can sometimes be associated with systemic diseases like malignancies or liver dysfunction.</p>
        <p>This course educates participants on the clinical presentation, differential diagnosis, and management strategies for pityriasis rotunda and emphasizes the importance of working with an interprofessional care team, including dermatologists, primary care providers, and pathologists, to ensure a comprehensive approach. By collaborating across disciplines, clinicians can improve diagnostic accuracy, provide individualized treatment plans, and optimize patient outcomes, particularly in cases where underlying systemic conditions may be involved.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the characteristic circular or oval hyperpigmented or hypopigmented scaly plaques associated with pityriasis rotunda.</p></list-item><list-item><p>Screen for potential underlying systemic conditions, including malignancies or liver dysfunction, that may be associated with pityriasis rotunda.&#x000a0;</p></list-item><list-item><p>Differentiate pityriasis rotunda from other dermatological conditions such as tinea corporis, psoriasis, or ichthyosis to ensure accurate diagnosis.</p></list-item><list-item><p>Communicate&#x000a0;the role of interprofessional team members in optimizing collaboration and communication to ensure patients with pityriasis rotunda receive high-quality care, which will lead to enhanced outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27256&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27256">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27256.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pityriasis rotunda is an uncommon acquired&#x000a0;dermatosis related to a keratinization disorder described&#x000a0;first&#x000a0;in 1906. This dermatosis was called pityriasis circinata and "pseudo-ichtyose acquise en taches circulaires," and is characterized by hyperpigmented or hypopigmented, sharply defined, circular, or oval scaly plaques of variable size, which develop on the trunk and proximal parts of the limbs. Pityriasis rotunda, not commonly encountered in some regions of the world, is not always easy to diagnose.<xref ref-type="bibr" rid="article-27256.r1">[1]</xref><xref ref-type="bibr" rid="article-27256.r2">[2]</xref><xref ref-type="bibr" rid="article-27256.r3">[3]</xref></p>
      </sec>
      <sec id="article-27256.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of pityriasis rotunda is not established. Authors have attached it to various disorders of keratinization, such as ichthyosis vulgaris, late-onset congenital ichthyosis, and acquired ichthyosis. Pityriasis rotunda is also considered a potential paraneoplastic dermatosis since it may be observed during certain malignancies, mainly hepatocellular carcinoma in Black patients from South African, but also the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Immunoglobulin G myeloma, multiple myeloma</p>
          </list-item>
          <list-item>
            <p>Acute myeloid leukemia</p>
          </list-item>
          <list-item>
            <p>Chronic myeloid leukemia</p>
          </list-item>
          <list-item>
            <p>Adenocarcinoma of the prostate</p>
          </list-item>
          <list-item>
            <p>Esophagus carcinoma</p>
          </list-item>
          <list-item>
            <p>Gastric carcinoma</p>
          </list-item>
          <list-item>
            <p>Squamous cell carcinoma of the palate</p>
          </list-item>
        </list>
        <p>Pityriasis rotunda&#x000a0;is also associated with several systemic diseases, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Malnutrition</p>
          </list-item>
          <list-item>
            <p>Diabetes mellitus</p>
          </list-item>
          <list-item>
            <p>Infections (tuberculosis, leprosy, osteitis)</p>
          </list-item>
          <list-item>
            <p>Hepatic diseases such as cirrhosis</p>
          </list-item>
          <list-item>
            <p>Chronic obstructive pulmonary disease and recurrent pulmonary infections</p>
          </list-item>
          <list-item>
            <p>Heart disease</p>
          </list-item>
          <list-item>
            <p>Female genital tract anomalies (ovarian cysts and fibroids)</p>
          </list-item>
          <list-item>
            <p>Glucose-6-phosphate dehydrogenase deficiency (favism)</p>
          </list-item>
          <list-item>
            <p>Chronic diarrhea</p>
          </list-item>
          <list-item>
            <p>Scleroderma</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Hormonal disorders such as hyperprolactinemia</p>
          </list-item>
        </list>
        <p>However, researchers&#x000a0;have not eliminated the idea that the association of some of these conditions associated with pityriasis rotunda,&#x000a0;especially favism,&#x000a0;could be due to chance.<xref ref-type="bibr" rid="article-27256.r4">[4]</xref><xref ref-type="bibr" rid="article-27256.r5">[5]</xref><xref ref-type="bibr" rid="article-27256.r6">[6]</xref><xref ref-type="bibr" rid="article-27256.r7">[7]</xref></p>
      </sec>
      <sec id="article-27256.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Pityriasis rotunda affects both sexes equally, although certain authors noticed a slight female predominance. The age for the diagnosis ranges from 20 to 45 years, with extremes of 2&#x000a0;and 87 years. There is a particular racial and geographic distribution for pityriasis rotunda. Most cases are reported in Japan and among West Indian and Black individuals in South Africa. Case reports of pityriasis rotunda in Black Americans are less common, and the frequency of the disease on the North American continent is not known. Cases of pityriasis rotunda among Caucasians are also rare. Mainly, cases are reported in Mediterranean patients, especially from Sardinia, Italy. Familial cases may also be observed and likely have a hereditary determinism which may be an autosomal dominant transmission.</p>
      </sec>
      <sec id="article-27256.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hashimoto et al described a diminished expression of loricrin and filaggrin in pityriasis rotunda lesions. According to Yoneda et al, a complete absence of the profilaggrin-N terminus domain is observed in the lesional skin. Makino et al reported a decrease in the expression of epidermal filaggrin 2, as seen in ichthyosis vulgaris, atopic dermatitis, and psoriasis vulgaris.</p>
      </sec>
      <sec id="article-27256.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathology of pityriasis rotunda lesions can reveal variable findings, including hyperkeratosis, which is mainly ortho-keratotic but can be para-keratotic, with plugs observed within hair follicles, elongated rete ridges, a diminished or absent stratum granulosum, slight spongiosis, enhanced pigmentation of the basal layer, pigmentary incontinence, and perivascular infiltrate of small lymphocytes. Periodic acid-Schiff stain for fungus is negative. These changes are similar to those observed in ichthyosis vulgaris. However, the histopathological aspect may be normal.</p>
        <p>Grimalt et al performed an ultrastructural study on pityriasis rotunda lesional skin biopsies. They noted the existence within the epidermis of vacuoles of lipid and crystal-like inclusions. Granules of keratohyalin were normal, and keratinosomes were increased. The stratum granulosum was reduced to 1 layer. The cementing substance connecting corneocytes was abundant. These findings suggest that pityriasis rotunda was more related to congenital ichthyosis than ichthyosis vulgaris.</p>
      </sec>
      <sec id="article-27256.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The diagnosis of pityriasis rotunda is usually based on clinical examination. Skin lesions are generally asymptomatic or mildly symptomatic. Pityriasis rotunda plaques are scaly, dry, sharply defined, and round, with prominent hair follicles but no inflammatory erythema. Scales may be highlighted by scratching the plaques. The lesions appear hypopigmented in fair-skinned patients and hyperpigmented in dark-skinned patients. The plaques of pityriasis rotunda may be confluent. Their size is variable (1 cm to more than 20 cm), and their number ranges from&#x000a0;1 to dozens but rarely exceeds 100. Pityriasis rotunda affects mainly the trunk (back and abdomen), buttocks, and proximal parts of the limbs (thighs and arms). The face, hands, and feet are usually not involved. In some patients, associated skin lesions of ichthyosis vulgaris may be observed. A familial history of ichthyosis vulgaris has been reported in certain patients with pityriasis rotunda.<xref ref-type="bibr" rid="article-27256.r8">[8]</xref><xref ref-type="bibr" rid="article-27256.r9">[9]</xref></p>
        <p>Grimalt et al proposed a classification of pityriasis rotunda. The first subtype consists of less than 30 hyperpigmented patches, mainly in black and Asian persons. No similar familial cases are seen in this subtype, but associated diseases are frequently described, such as malignancies (solid tumors and hemopathies), systemic diseases, and infections. A second subtype is characterized by more than 30 hypopigmented patches, occurring mainly in white patients with a familial history of similar skin lesions. There usually is no underlying disease. This classification is schematic since overlap cases have been reported. The clinical differential diagnosis includes tinea versicolor, erythrasma, tinea corporis, nummular eczema, early-stage mycosis fungoides, fixed drug reaction, pityriasis rosea, pityriasis alba, figurate erythema, and leprosy.</p>
      </sec>
      <sec id="article-27256.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Mycological examination of scaly material removed from lesional skin (direct microscopy using potassium hydroxide and fungal culture) is useful to rule out a dermatomycosis. Wood light examination is used if erythrasma is suspected.</p>
      </sec>
      <sec id="article-27256.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management of pityriasis rotunda is often challenging. Topical corticosteroids, antifungal agents, emollients, tars, and keratolytic topicals (salicylic acid and lactic acid) are poorly efficient. Retinoids, either topicals (retinoic acid and tazarotene) or oral (etretinate) have been used with little or no success in pityriasis rotunda. Treatment with vitamin D3 analogs such as calcipotriol&#x000a0;leads to a progressive improvement in the lesions in a few patients.&#x000a0;However, for patients with comorbidities, successful treatment of the underlying disease often leads to remission of pityriasis rotunda lesions.</p>
      </sec>
      <sec id="article-27256.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnoses for pityriasis rotunda include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Erythrasma</p>
          </list-item>
          <list-item>
            <p>Leprosy</p>
          </list-item>
          <list-item>
            <p>Parapsoriasis</p>
          </list-item>
          <list-item>
            <p>Pityriasis alba&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pityriasis rosea</p>
          </list-item>
          <list-item>
            <p>Plaque psoriasis</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Tinea corporis</p>
          </list-item>
          <list-item>
            <p>Tinea cruris</p>
          </list-item>
          <list-item>
            <p>Tinea versicolor</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27256.s11" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Skin lesions of pityriasis rotunda have a chronic course and can persist for months to years, with alternating periods of exacerbation (especially during winter or pregnancy) and remission. Follow-up of pityriasis rotunda skin lesions without treatment is the other option because of possible spontaneous resolution. Since underlying diseases, mainly malignancies, have been associated with pityriasis rotunda, physicians should be aware of the importance of ruling out such diseases based on anamnesis, physical examination, and appropriate investigations.</p>
      </sec>
      <sec id="article-27256.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pityriasis rotunda is a rare skin disorder that is not easy to diagnose. The condition may be seen by the primary care provider, but because of the complexity of the diagnosis, it is best managed by a dermatologist. Once diagnosed, the management of pityriasis rotunda is often challenging. Topical corticosteroids, antifungal agents, emollients, tars, and keratolytic topicals (salicylic acid and lactic acid) are poorly efficient. Retinoids, either topicals (retinoic acid and tazarotene) or oral (etretinate) have been used with little or no success in pityriasis rotunda. Treatment with vitamin D3 analogs such as calcipotriol&#x000a0;leads to a progressive improvement in the lesions in a few patients. he skin condition can take months or even years to disappear. However, for patients with comorbidities, successful treatment of the underlying disease often leads to remission of pityriasis rotunda lesions. Because of the few cases, there are no evidence-based guidelines on managing this disorder.</p>
      </sec>
      <sec id="article-27256.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27256&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27256">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/pityriasis-rotunda/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27256">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27256/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27256">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27256.s14">
        <title>References</title>
        <ref id="article-27256.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Refu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Al-Tarawneh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Odeibat</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rotunda. A clinical study in Jordan: experience of 10 years.</article-title>
            <source>Int J Dermatol</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>57</volume>
            <issue>7</issue>
            <fpage>759</fpage>
            <page-range>759-762</page-range>
            <pub-id pub-id-type="pmid">29774541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aoshima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fujiyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tokura</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rotunda associated with acute myeloid leukemia.</article-title>
            <source>J Dermatol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-106</page-range>
            <pub-id pub-id-type="pmid">28370261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaccaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salpietro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Foti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borgia</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lentini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cannav&#x000f2;</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rotunda with recurrent respiratory infections.</article-title>
            <source>G Ital Dermatol Venereol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>152</volume>
            <issue>2</issue>
            <fpage>190</fpage>
            <page-range>190-191</page-range>
            <pub-id pub-id-type="pmid">28166620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lefkowitz</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Natow</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis Rotunda: A Case Report of Familial Disease in an American-Born Black Patient.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2016</year>
            <season>Jan-Apr</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-4</page-range>
            <pub-id pub-id-type="pmid">27065844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinos-Le&#x000f3;n</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>N&#x000fa;&#x000f1;ez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salazar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sol&#x000ed;s-Bowen</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis Rotunda and Hyperprolactinemia.</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2016</year>
            <season>Jul-Aug</season>
            <volume>107</volume>
            <issue>6</issue>
            <fpage>535</fpage>
            <page-range>535-7</page-range>
            <pub-id pub-id-type="pmid">27006018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mizawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Decreased filaggrin-2 expression in the epidermis in a case of pityriasis rotunda.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>215</fpage>
            <page-range>215-7</page-range>
            <pub-id pub-id-type="pmid">26189536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Heerden</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rotunda as an incidental paraneoplastic finding in two patients with multiple myeloma.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>734</fpage>
            <page-range>734-7</page-range>
            <pub-id pub-id-type="pmid">24985090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zur</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Shapero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shapero</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis rotunda diagnosed in Canada: case presentation and review of the literature.</article-title>
            <source>J Cutan Med Surg</source>
            <year>2013</year>
            <season>Nov-Dec</season>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-8</page-range>
            <pub-id pub-id-type="pmid">24138982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27256.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirsky</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Watters</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jafarian</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Chronic hyperpigmented scaly plaques. Pityriasis rotunda (PR).</article-title>
            <source>Arch Dermatol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>148</volume>
            <issue>9</issue>
            <fpage>1073</fpage>
            <page-range>1073-8</page-range>
            <pub-id pub-id-type="pmid">22986863</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
